Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

When Will Clinical Trials Finally Reflect Diversity?

Simari RD.

Circulation. 2019 Sep 24;140(13):1048-1049. doi: 10.1161/CIRCULATIONAHA.119.040147. Epub 2019 Sep 23. No abstract available.

PMID:
31545686
2.

Vasculogenic properties of adventitial Sca-1+CD45+ progenitor cells in mice: a potential source of vasa vasorum in atherosclerosis.

Toledo-Flores D, Williamson A, Schwarz N, Fernando S, Dimasi C, Witt TA, Nguyen TM, Puranik AS, Chue CD, Delacroix S, Spoon DB, Bonder CS, Bursill CA, Di Bartolo BA, Nicholls SJ, Simari RD, Psaltis PJ.

Sci Rep. 2019 May 13;9(1):7286. doi: 10.1038/s41598-019-43765-8.

3.

Progress in Drug Discovery in Academia and Persistent Challenges of "the Valley of Death".

Barohn RJ, Weir SJ, Simari RD.

Mayo Clin Proc. 2019 Mar;94(3):391-393. doi: 10.1016/j.mayocp.2019.01.014. No abstract available.

PMID:
30832788
4.

Cardiac Valve Bioreactor for Physiological Conditioning and Hydrodynamic Performance Assessment.

Tefft BJ, Choe JA, Young MD, Hennessy RS, Morse DW, Bouchard JA, Hedberg HJ, Consiglio JF, Dragomir-Daescu D, Simari RD, Lerman A.

Cardiovasc Eng Technol. 2019 Mar;10(1):80-94. doi: 10.1007/s13239-018-00382-2. Epub 2018 Oct 11.

PMID:
30311149
5.

Kidney-resident macrophages promote a proangiogenic environment in the normal and chronically ischemic mouse kidney.

Puranik AS, Leaf IA, Jensen MA, Hedayat AF, Saad A, Kim KW, Saadalla AM, Woollard JR, Kashyap S, Textor SC, Grande JP, Lerman A, Simari RD, Randolph GJ, Duffield JS, Lerman LO.

Sci Rep. 2018 Sep 17;8(1):13948. doi: 10.1038/s41598-018-31887-4.

6.

Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial.

Bolli R, Hare JM, Henry TD, Lenneman CG, March KL, Miller K, Pepine CJ, Perin EC, Traverse JH, Willerson JT, Yang PC, Gee AP, Lima JA, Moyé L, Vojvodic RW, Sayre SL, Bettencourt J, Cohen M, Ebert RF, Simari RD; Cardiovascular Cell Therapy Research Network (CCTRN).

Am Heart J. 2018 Jul;201:54-62. doi: 10.1016/j.ahj.2018.02.009. Epub 2018 Apr 4.

PMID:
29910056
7.

Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure).

Bolli R, Hare JM, March KL, Pepine CJ, Willerson JT, Perin EC, Yang PC, Henry TD, Traverse JH, Mitrani RD, Khan A, Hernandez-Schulman I, Taylor DA, DiFede DL, Lima JAC, Chugh A, Loughran J, Vojvodic RW, Sayre SL, Bettencourt J, Cohen M, Moyé L, Ebert RF, Simari RD; Cardiovascular Cell Therapy Research Network (CCTRN).

Circ Res. 2018 Jun 8;122(12):1703-1715. doi: 10.1161/CIRCRESAHA.118.312978. Epub 2018 Apr 27.

8.

Nanoparticle-Mediated Cell Capture Enables Rapid Endothelialization of a Novel Bare Metal Stent.

Tefft BJ, Uthamaraj S, Harbuzariu A, Harburn JJ, Witt TA, Newman B, Psaltis PJ, Hlinomaz O, Holmes DR Jr, Gulati R, Simari RD, Dragomir-Daescu D, Sandhu GS.

Tissue Eng Part A. 2018 Jul;24(13-14):1157-1166. doi: 10.1089/ten.TEA.2017.0404. Epub 2018 Mar 13.

9.

Global Overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Recommendations: A Comprehensive Series of Challenges and Priorities of Cardiovascular Regenerative Medicine.

Fernández-Avilés F, Sanz-Ruiz R, Climent AM, Badimon L, Bolli R, Charron D, Fuster V, Janssens S, Kastrup J, Kim HS, Lüscher TF, Martin JF, Menasché P, Pinto FJ, Simari RD, Stone GW, Terzic A, Willerson JT, Wu JC; TACTICS Writing Group.

Circ Res. 2018 Jan 19;122(2):199-201. doi: 10.1161/CIRCRESAHA.117.312099. No abstract available.

PMID:
29348246
10.

TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis.

Traverse JH, Henry TD, Pepine CJ, Willerson JT, Chugh A, Yang PC, Zhao DXM, Ellis SG, Forder JR, Perin EC, Penn MS, Hatzopoulos AK, Chambers JC, Baran KW, Raveendran G, Gee AP, Taylor DA, Moyé L, Ebert RF, Simari RD.

Circ Res. 2018 Feb 2;122(3):479-488. doi: 10.1161/CIRCRESAHA.117.311466. Epub 2017 Dec 5.

11.

Recellularization of a novel off-the-shelf valve following xenogenic implantation into the right ventricular outflow tract.

Hennessy RS, Go JL, Hennessy RR, Tefft BJ, Jana S, Stoyles NJ, Al-Hijji MA, Thaden JJ, Pislaru SV, Simari RD, Stulak JM, Young MD, Lerman A.

PLoS One. 2017 Aug 1;12(8):e0181614. doi: 10.1371/journal.pone.0181614. eCollection 2017.

12.

Xenoantigenicity of porcine decellularized valves.

Helder MRK, Stoyles NJ, Tefft BJ, Hennessy RS, Hennessy RRC, Dyer R, Witt T, Simari RD, Lerman A.

J Cardiothorac Surg. 2017 Jul 17;12(1):56. doi: 10.1186/s13019-017-0621-5.

13.

Forging the Fate of Cellular Therapies for Cardiovascular Disease.

Simari RD.

Circ Res. 2017 Jun 9;120(12):1871-1873. doi: 10.1161/CIRCRESAHA.117.310970. Review. No abstract available.

14.

Global position paper on cardiovascular regenerative medicine.

Fernández-Avilés F, Sanz-Ruiz R, Climent AM, Badimon L, Bolli R, Charron D, Fuster V, Janssens S, Kastrup J, Kim HS, Lüscher TF, Martin JF, Menasché P, Simari RD, Stone GW, Terzic A, Willerson JT, Wu JC; TACTICS (Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes) Writing Group; Authors/Task Force Members. Chairpersons; Basic Research Subcommittee; Translational Research Subcommittee; Challenges of Cardiovascular Regenerative Medicine Subcommittee; Tissue Engineering Subcommittee; Delivery, Navigation, Tracking and Assessment Subcommittee; Clinical Trials Subcommittee; Regulatory and funding strategies subcommittee; Delivery, Navigation, Tracking and Assessment Subcommittee.

Eur Heart J. 2017 Sep 1;38(33):2532-2546. doi: 10.1093/eurheartj/ehx248. Review. No abstract available. Erratum in: Eur Heart J. 2018 May 14;39(19):1723.

15.

Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells).

Perin EC, Murphy MP, March KL, Bolli R, Loughran J, Yang PC, Leeper NJ, Dalman RL, Alexander J, Henry TD, Traverse JH, Pepine CJ, Anderson RD, Berceli S, Willerson JT, Muthupillai R, Gahremanpour A, Raveendran G, Velasquez O, Hare JM, Hernandez Schulman I, Kasi VS, Hiatt WR, Ambale-Venkatesh B, Lima JA, Taylor DA, Resende M, Gee AP, Durett AG, Bloom J, Richman S, G'Sell P, Williams S, Khan F, Gyang Ross E, Santoso MR, Goldman J, Leach D, Handberg E, Cheong B, Piece N, DiFede D, Bruhn-Ding B, Caldwell E, Bettencourt J, Lai D, Piller L, Simpson L, Cohen M, Sayre SL, Vojvodic RW, Moyé L, Ebert RF, Simari RD, Hirsch AT; Cardiovascular Cell Therapy Research Network (CCTRN).

Circulation. 2017 Apr 11;135(15):1417-1428. doi: 10.1161/CIRCULATIONAHA.116.025707. Epub 2017 Feb 16.

16.

Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial.

Bhatnagar A, Bolli R, Johnstone BH, Traverse JH, Henry TD, Pepine CJ, Willerson JT, Perin EC, Ellis SG, Zhao DX, Yang PC, Cooke JP, Schutt RC, Trachtenberg BH, Orozco A, Resende M, Ebert RF, Sayre SL, Simari RD, Moyé L, Cogle CR, Taylor DA; Cardiovascular Cell Therapy Research Network (CCTRN).

Am Heart J. 2016 Sep;179:142-50. doi: 10.1016/j.ahj.2016.06.018. Epub 2016 Jul 6.

17.

Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease.

Golpanian S, Schulman IH, Ebert RF, Heldman AW, DiFede DL, Yang PC, Wu JC, Bolli R, Perin EC, Moyé L, Simari RD, Wolf A, Hare JM; Cardiovascular Cell Therapy Research Network.

Stem Cells Transl Med. 2016 Feb;5(2):186-91. doi: 10.5966/sctm.2015-0101. Epub 2015 Dec 18. Review.

18.

Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial.

Taylor DA, Perin EC, Willerson JT, Zierold C, Resende M, Carlson M, Nestor B, Wise E, Orozco A, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Traverse JH, Cooke JP, Schutt RC, Bhatnagar A, Grant MB, Lai D, Johnstone BH, Sayre SL, Moyé L, Ebert RF, Bolli R, Simari RD, Cogle CR; Cardiovascular Cell Therapy Research Network (CCTRN).

Cell Transplant. 2016;25(9):1675-1687. Epub 2015 Nov 19.

19.

Corrigendum to "Scaffolds for tissue engineering of cardiac valves" [Acta Biomater. 10 (2014) 2877-2893].

Jana S, Tefft BJ, Spoon DB, Simari RD.

Acta Biomater. 2015 Nov;27:305. doi: 10.1016/j.actbio.2015.06.029. Epub 2015 Jun 24. No abstract available.

PMID:
29080773
20.

Low-Dose Gamma Irradiation of Decellularized Heart Valves Results in Tissue Injury In Vitro and In Vivo.

Helder MR, Hennessy RS, Spoon DB, Tefft BJ, Witt TA, Marler RJ, Pislaru SV, Simari RD, Stulak JM, Lerman A.

Ann Thorac Surg. 2016 Feb;101(2):667-74. doi: 10.1016/j.athoracsur.2015.07.080. Epub 2015 Oct 9.

21.

In Vitro Model of a Fibrosa Layer of a Heart Valve.

Jana S, Lerman A, Simari RD.

ACS Appl Mater Interfaces. 2015 Sep 16;7(36):20012-20. doi: 10.1021/acsami.5b04805. Epub 2015 Sep 1.

PMID:
26295833
22.

Vascular wall progenitor cells in health and disease.

Psaltis PJ, Simari RD.

Circ Res. 2015 Apr 10;116(8):1392-412. doi: 10.1161/CIRCRESAHA.116.305368. Review.

PMID:
25858065
23.

Osteogenic monocytes within the coronary circulation and their association with plaque vulnerability in patients with early atherosclerosis.

Collin J, Gössl M, Matsuo Y, Cilluffo RR, Flammer AJ, Loeffler D, Lennon RJ, Simari RD, Spoon DB, Erbel R, Lerman LO, Khosla S, Lerman A.

Int J Cardiol. 2015 Feb 15;181:57-64. doi: 10.1016/j.ijcard.2014.11.156. Epub 2014 Nov 26.

24.

Drug delivery in aortic valve tissue engineering.

Jana S, Simari RD, Spoon DB, Lerman A.

J Control Release. 2014 Dec 28;196:307-23. doi: 10.1016/j.jconrel.2014.10.009. Epub 2014 Oct 22. Review.

PMID:
25459428
25.

Cell surface protein disulfide isomerase regulates natriuretic peptide generation of cyclic guanosine monophosphate.

Pan S, Chen HH, Correia C, Dai H, Witt TA, Kleppe LS, Burnett JC Jr, Simari RD.

PLoS One. 2014 Nov 24;9(11):e112986. doi: 10.1371/journal.pone.0112986. eCollection 2014.

26.

Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial.

Schutt RC, Trachtenberg BH, Cooke JP, Traverse JH, Henry TD, Pepine CJ, Willerson JT, Perin EC, Ellis SG, Zhao DX, Bhatnagar A, Johnstone BH, Lai D, Resende M, Ebert RF, Wu JC, Sayre SL, Orozco A, Zierold C, Simari RD, Moyé L, Cogle CR, Taylor DA; Cardiovascular Cell Therapy Research Network (CCTRN).

Circ Res. 2015 Jan 2;116(1):99-107. doi: 10.1161/CIRCRESAHA.116.304710. Epub 2014 Nov 18.

27.

Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces.

Simonetto DA, Yang HY, Yin M, de Assuncao TM, Kwon JH, Hilscher M, Pan S, Yang L, Bi Y, Beyder A, Cao S, Simari RD, Ehman R, Kamath PS, Shah VH.

Hepatology. 2015 Feb;61(2):648-59. doi: 10.1002/hep.27387. Epub 2015 Jan 5.

28.

Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.

Cogle CR, Wise E, Meacham AM, Zierold C, Traverse JH, Henry TD, Perin EC, Willerson JT, Ellis SG, Carlson M, Zhao DX, Bolli R, Cooke JP, Anwaruddin S, Bhatnagar A, da Graca Cabreira-Hansen M, Grant MB, Lai D, Moyé L, Ebert RF, Olson RE, Sayre SL, Schulman IH, Bosse RC, Scott EW, Simari RD, Pepine CJ, Taylor DA; Cardiovascular Cell Therapy Research Network (CCTRN).

Circ Res. 2014 Oct 24;115(10):867-74. doi: 10.1161/CIRCRESAHA.115.304353. Epub 2014 Aug 18.

29.

Characterization of a resident population of adventitial macrophage progenitor cells in postnatal vasculature.

Psaltis PJ, Puranik AS, Spoon DB, Chue CD, Hoffman SJ, Witt TA, Delacroix S, Kleppe LS, Mueske CS, Pan S, Gulati R, Simari RD.

Circ Res. 2014 Jul 18;115(3):364-75. doi: 10.1161/CIRCRESAHA.115.303299. Epub 2014 Jun 6.

PMID:
24906644
30.

Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network.

Simari RD, Pepine CJ, Traverse JH, Henry TD, Bolli R, Spoon DB, Yeh E, Hare JM, Schulman IH, Anderson RD, Lambert C, Sayre SL, Taylor DA, Ebert RF, Moyé LA.

Circ Res. 2014 May 9;114(10):1564-8. doi: 10.1161/CIRCRESAHA.114.303720. Review.

31.

Scaffolds for tissue engineering of cardiac valves.

Jana S, Tefft BJ, Spoon DB, Simari RD.

Acta Biomater. 2014 Jul;10(7):2877-93. doi: 10.1016/j.actbio.2014.03.014. Epub 2014 Mar 24. Review. Erratum in: Acta Biomater. 2015 Nov;27:305.

PMID:
24675108
32.

Trends in cause of death after percutaneous coronary intervention.

Spoon DB, Psaltis PJ, Singh M, Holmes DR Jr, Gersh BJ, Rihal CS, Lennon RJ, Moussa ID, Simari RD, Gulati R.

Circulation. 2014 Mar 25;129(12):1286-94. doi: 10.1161/CIRCULATIONAHA.113.006518. Epub 2014 Feb 10.

PMID:
24515993
33.

Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis.

Delewi R, Hirsch A, Tijssen JG, Schächinger V, Wojakowski W, Roncalli J, Aakhus S, Erbs S, Assmus B, Tendera M, Goekmen Turan R, Corti R, Henry T, Lemarchand P, Lunde K, Cao F, Huikuri HV, Sürder D, Simari RD, Janssens S, Wollert KC, Plewka M, Grajek S, Traverse JH, Zijlstra F, Piek JJ.

Eur Heart J. 2014 Apr;35(15):989-98. doi: 10.1093/eurheartj/eht372. Epub 2013 Sep 11. Review.

34.

Noninvasive monitoring of oxidative stress in transplanted mesenchymal stromal cells.

Psaltis PJ, Peterson KM, Xu R, Franchi F, Witt T, Chen IY, Lerman A, Simari RD, Gambhir SS, Rodriguez-Porcel M.

JACC Cardiovasc Imaging. 2013 Jul;6(7):795-802. doi: 10.1016/j.jcmg.2012.11.018. Epub 2013 May 1.

35.

Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN).

Hare JM, Bolli R, Cooke JP, Gordon DJ, Henry TD, Perin EC, March KL, Murphy MP, Pepine CJ, Simari RD, Skarlatos SI, Traverse JH, Willerson JT, Szady AD, Taylor DA, Vojvodic RW, Yang PC, Moyé LA; Cardiovascular Cell Therapy Research Network.

Circulation. 2013 Apr 16;127(15):1630-5. doi: 10.1161/CIRCULATIONAHA.112.000779. No abstract available.

36.

Bone marrow-derived cell therapy after myocardial infarction.

Moyé LA, Simari RD, Skarlatos SI; Cardiovascular Cell Therapy Research Network (CCTRN).

JAMA. 2013 Apr 10;309(14):1459. doi: 10.1001/jama.2013.2601. No abstract available.

37.

Endothelial outgrowth cells shift macrophage phenotype and improve kidney viability in swine renal artery stenosis.

Eirin A, Zhu XY, Li Z, Ebrahimi B, Zhang X, Tang H, Korsmo MJ, Chade AR, Grande JP, Ward CJ, Simari RD, Lerman A, Textor SC, Lerman LO.

Arterioscler Thromb Vasc Biol. 2013 May;33(5):1006-13. doi: 10.1161/ATVBAHA.113.301164. Epub 2013 Feb 21.

38.

Inhibition of p38 MAPK attenuates renal atrophy and fibrosis in a murine renal artery stenosis model.

Wang D, Warner GM, Yin P, Knudsen BE, Cheng J, Butters KA, Lien KR, Gray CE, Garovic VD, Lerman LO, Textor SC, Nath KA, Simari RD, Grande JP.

Am J Physiol Renal Physiol. 2013 Apr 1;304(7):F938-47. doi: 10.1152/ajprenal.00706.2012. Epub 2013 Jan 30.

39.

Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.

Traverse JH, Henry TD, Pepine CJ, Willerson JT, Zhao DX, Ellis SG, Forder JR, Anderson RD, Hatzopoulos AK, Penn MS, Perin EC, Chambers J, Baran KW, Raveendran G, Lambert C, Lerman A, Simon DI, Vaughan DE, Lai D, Gee AP, Taylor DA, Cogle CR, Thomas JD, Olson RE, Bowman S, Francescon J, Geither C, Handberg E, Kappenman C, Westbrook L, Piller LB, Simpson LM, Baraniuk S, Loghin C, Aguilar D, Richman S, Zierold C, Spoon DB, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD; Cardiovascular Cell Therapy Research Network (CCTRN).

JAMA. 2012 Dec 12;308(22):2380-9. Erratum in: JAMA. 2013 Jan 23;309(4):343. Erratum in: JAMA. 2015 Jul 7;314(1):86.

40.

An in vivo method to quantify lymphangiogenesis in zebrafish.

Hoffman SJ, Psaltis PJ, Clark KJ, Spoon DB, Chue CD, Ekker SC, Simari RD.

PLoS One. 2012;7(9):e45240. doi: 10.1371/journal.pone.0045240. Epub 2012 Sep 13.

41.

Patients with an HbA1c in the prediabetic and diabetic range have higher numbers of circulating cells with osteogenic and endothelial progenitor cell markers.

Flammer AJ, Gössl M, Li J, Matsuo Y, Reriani M, Loeffler D, Simari RD, Lerman LO, Khosla S, Lerman A.

J Clin Endocrinol Metab. 2012 Dec;97(12):4761-8. doi: 10.1210/jc.2012-2642. Epub 2012 Sep 26.

42.

Levoatriocardinal vein with partial anomalous venous return and a bidirectional shunt.

Cullen EL, Breen JF, Rihal CS, Simari RD, Ammash NM.

Circulation. 2012 Sep 18;126(12):e174-7. doi: 10.1161/CIRCULATIONAHA.111.085555. No abstract available.

PMID:
22988048
43.

Osteocalcin positive CD133+/CD34-/KDR+ progenitor cells as an independent marker for unstable atherosclerosis.

Flammer AJ, Gössl M, Widmer RJ, Reriani M, Lennon R, Loeffler D, Shonyo S, Simari RD, Lerman LO, Khosla S, Lerman A.

Eur Heart J. 2012 Dec;33(23):2963-9. doi: 10.1093/eurheartj/ehs234. Epub 2012 Jul 31.

44.

Clinical features, management, and prognosis of spontaneous coronary artery dissection.

Tweet MS, Hayes SN, Pitta SR, Simari RD, Lerman A, Lennon RJ, Gersh BJ, Khambatta S, Best PJ, Rihal CS, Gulati R.

Circulation. 2012 Jul 31;126(5):579-88. doi: 10.1161/CIRCULATIONAHA.112.105718. Epub 2012 Jul 16.

PMID:
22800851
45.

Cell tracking and the development of cell-based therapies: a view from the Cardiovascular Cell Therapy Research Network.

Rodriguez-Porcel M, Kronenberg MW, Henry TD, Traverse JH, Pepine CJ, Ellis SG, Willerson JT, Moyé LA, Simari RD.

JACC Cardiovasc Imaging. 2012 May;5(5):559-65. doi: 10.1016/j.jcmg.2011.12.018. Review.

46.

Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.

Perin EC, Willerson JT, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Silva GV, Lai D, Thomas JD, Kronenberg MW, Martin AD, Anderson RD, Traverse JH, Penn MS, Anwaruddin S, Hatzopoulos AK, Gee AP, Taylor DA, Cogle CR, Smith D, Westbrook L, Chen J, Handberg E, Olson RE, Geither C, Bowman S, Francescon J, Baraniuk S, Piller LB, Simpson LM, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD; Cardiovascular Cell Therapy Research Network (CCTRN).

JAMA. 2012 Apr 25;307(16):1717-26. doi: 10.1001/jama.2012.418. Epub 2012 Mar 24. Erratum in: JAMA. 2015 Jul 7;314(1):86.

47.

Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) study.

Richman S, Gee AP, McKenna DH, Traverse JH, Henry TD, Fisk D, Pepine CJ, Bloom J, Willerson JT, Prater K, Zhao D, Koç JR, Anwaruddin S, Taylor DA, Cogle CR, Moyé LA, Simari RD, Skarlatos SI.

Transfusion. 2012 Oct;52(10):2225-33. doi: 10.1111/j.1537-2995.2011.03543.x. Epub 2012 Feb 10.

48.

Tissue factor pathway inhibitor blocks angiogenesis via its carboxyl terminus.

Holroyd EW, Delacroix S, Larsen K, Harbuzariu A, Psaltis PJ, Wang L, Pan S, White TA, Witt TA, Kleppe LS, Mueske CS, Mukhopadhyay D, Simari RD.

Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):704-11. doi: 10.1161/ATVBAHA.111.243733. Epub 2012 Jan 5.

49.

Identification of a monocyte-predisposed hierarchy of hematopoietic progenitor cells in the adventitia of postnatal murine aorta.

Psaltis PJ, Harbuzariu A, Delacroix S, Witt TA, Holroyd EW, Spoon DB, Hoffman SJ, Pan S, Kleppe LS, Mueske CS, Gulati R, Sandhu GS, Simari RD.

Circulation. 2012 Jan 31;125(4):592-603. doi: 10.1161/CIRCULATIONAHA.111.059360. Epub 2011 Dec 27.

50.

Tissue factor pathway inhibitor as a multifunctional mediator of vascular structure.

Holroyd EW, White TA, Pan S, Simari RD.

Front Biosci (Elite Ed). 2012 Jan 1;4:392-400. Review.

Supplemental Content

Loading ...
Support Center